Riskpilot← Back to searchSign inGet full accessSvarwen AB
ABActiveOrg 5567613574Hamngatan 6Dental practice care activities · NACE 8623Est. 20082 employees
Revenue 2024
SEK 4M
+10% vs 2023
EBITDA margin
31.0%
+10% vs 2023
Equity ratio
95.3%
Financial strength
Net profit 2024
SEK 912K
-4% vs 2023
| Revenue | SEK 4M | +10% |
| EBITDA | SEK 1,2M | +10% |
| Net profit | SEK 912K | -4% |
| Total assets | SEK 4,6M | -5% |
| Equity | SEK 4,4M | -2% |
| Employees | 2 | — |
Legal name
Svarwen AB
Org number
5567613574
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
2 juli 2008
Share capital
SEK 100 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva tandläkarverksamhet och därmed förenlig verksamhet.
Address
Hamngatan 6
Phone
+4687837885
Email
info@vaxholmstandklinik.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 431 | 2 784 | 3 249 | 3 631 | 3 983 |
| Staff expenses | — | — | — | −1 277 | −1 319 |
| EBITDA | 333 | 579 | 1 181 | 1 126 | 1 234 |
| Depreciation & amort. | −99 | −74 | −4 | −13 | −37 |
| EBIT | 234 | 505 | 1 177 | 1 113 | 1 197 |
| Net financials | 31 | −1 | 124 | 6 | 0 |
| Profit before tax | 399 | 697 | 1 410 | 1 210 | 1 153 |
| Tax | −84 | −148 | −271 | −256 | −241 |
| Net profit | 315 | 549 | 1 139 | 954 | 912 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 250 | 3 430 | 4 334 | 4 807 | 4 578 |
| Equity | 2 710 | 3 059 | 3 998 | 4 452 | 4 363 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 132 | 156 | 229 | 340 | 155 |
| Total debt | 132 | 156 | 229 | 340 | 155 |
EBITDA margin
31.0%
This company
15.8%
Market median
+96% vs market
20202024
Equity ratio
95.3%
This company
38.2%
Market median
+149% vs market
20202024
Return on equity
20.9%
This company
18.4%
Market median
+14% vs market
20202024
Net profit margin
22.9%
This company
8.1%
Market median
+183% vs market
20202024
Asset turnover
0.87×
This company
1.12×
Market median
+22% vs market
20202024
Debt / equity
0.05×
This company
0.62×
Market median
+92% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
NM Audit | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Svarwen AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nils Magnus Robrandt | Audit | 0 companies |
| Dick Conny Gullmar Larsson | Deputy Board Member | 0 companies |
| Anna Cecilia Ljungberg | Board of Directors | 0 companies |